The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene

Oncogene

Volumn 24, Issue 48, 2005, Pages 7248-7252

  Bousquet, Marina ^a   Quelen, Cathy ^a   De Mas, Véronique ^a   Duchayne, Eliane ^a   Roquefeuil, Blandine ^a   Delsol, Georges ^a   Laurent, Guy ^a   Dastugue, Nicole ^a   Brousset, Pierre ^a  

^a CHU PURPAN   (France)

Author keywords

Atypical chronic myeloid leukaemia; JAK2; PCM1

Indexed keywords

JANUS KINASE 2; PROTEIN TYROSINE KINASE;

ADULT; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CASE REPORT; CHIMERA; CHROMOSOME 22P; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 8; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; ENZYME ACTIVITY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE FUSION; GENE LOCUS; HUMAN; MALE; METAPHASE; NUCLEOTIDE SEQUENCE; PERICENTRIOLAR MATERIAL 1 GENE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TARGET CELL DESTRUCTION;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; AUTOANTIGENS; CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, PAIR 8; CHROMOSOMES, HUMAN, PAIR 9; CYTARABINE; FATAL OUTCOME; HUMANS; HYDROXYUREA; IDARUBICIN; IN SITU HYBRIDIZATION, FLUORESCENCE; JANUS KINASE 2; KARYOTYPING; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; OPEN READING FRAMES; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA; TRANSLOCATION, GENETIC; TREATMENT OUTCOME; VARIATION (GENETICS);

BACTERIA (MICROORGANISMS);

EID: 27944481825     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208850     Document Type: Article

References (23)

1. Balczon R, Bao L and Zimmer WE. (1994). J. Cell Biol., 124, 783-793.
2. Balczon R, Simerly C, Takahashi D and Schatten G. (2002). Cell Motil. Cytoskeleton., 52, 183-192.
3. Barber DL and D'Andrea AD. (1994). Mol. Cell. Biol., 14, 6506-6514.
4. Baxter EJ, Hochhaus A, Bolufer P, Reiter A, Fernandez JM, Senent L, Cervera J, Moscardo F, Sanz MA and Cross NC. (2002). Hum. Mol. Genet., 11, 1391-1397.
5. Baxter EJ, Kulkarni S, Vizmanos JL, Jaju R, Martinelli G, Testoni N, Hughes G, Salamanchuk Z, Calasanz MJ, Lahortiga I, Pocock CF, Dang R, Fidler C, Wainscoat JS, Boultwood J and Cross NC. (2003). Br. J. Haematol., 120, 251-256.
6. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA, Erber WN and Green AR. (2005). Lancet, 365, 1054-1061.
7. Bhattacharya N, Tripathi A, Dasgupta S, Sabbir MG, Roy A, Sengupta A, Roy B, Roychowdhury S and Panda CK. (2003). Indian J. Med. Res., 118, 77-85.
8. Carron C, Cormier F, Janin A, Lacronique V, Giovannini M, Daniel MT, Bernard O and Ghysdael J. (2000). Blood, 95, 3891-3899.
9. Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, Kutok J, Clark J, Galinsky I, Griffin JD, Cross NC, Tefferi A, Malone J, Alam R, Schrier SL, Schmid J, Rose M, Vandenberghe P, Verhoef G, Boogaerts M, Wlodarska I, Kantarjian H, Marynen P, Coutre SE, Stone R and Gilliland DG. (2003). N. Engl. J. Med., 348, 1201-1214.
10. Corvi R, Berger N, Balczon R and Romeo G. (2000). Oncogene, 19, 4236-4242.
11. Dammermann A, Muller-Reichert T, Pelletier L, Habermann B, Desai A and Oegema K. (2004). Dev. Cell., 7, 815-829.
12. Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R and Talpaz M. (2001). N. Engl. J. Med., 344, 1038-1042.
13. Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M and Nakamura Y. (1992). Cancer Res., 52, 5368-5372.
14. Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CD and Fletcher JA. (2003). Science, 299, 708-710.
15. Heisterkamp N, Stephenson JR, Groffen J, Hansen PF, de Klein A, Bartram CR and Grosveld G. (1983). Nature, 306, 239-242.
16. James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C, Garcon L, Raslova H, Berger R, Bennaceur-Griscelli A, Villeval JL, Constantinescu SN, Casadevall N and Vainchenker W. (2005). Nature, 434, 1144-1148.
17. Lacronique V, Boureux A, Valle VD, Poirel H, Quang CT, Mauchauffe M, Berthou C, Lessard M, Berger R, Ghysdael J and Bernard OA. (1997). Science, 278, 1309-1312.
18. Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ, Boggon TJ, Wlodarska I, Clark JJ, Moore S, Adelsperger J, Koo S, Lee JC, Gabriel S, Mercher T, D'Andrea A, Frohling S, Dohner K, Marynen P, Vandenberghe P, Mesa RA, Tefferi A, Griffin JD, Eck MJ, Sellers WR, Meyerson M, Golub TR, Lee SJ and Gilliland DG. (2005). Cancer cell, 7, 387-397.
19. Nguyen MH, Ho JM, Beattie BK and Barber DL. (2001). J. Biol. Chem., 276, 32704-32713.
20. Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P, Monpoux F, Van Rompaey L, Baens M, Van den Berghe H and Marynen P. (1997). Blood, 90, 2535-2540.
21. Reiter A, Walz C, Watmore A, Schoch C, Blau I, Schlegelberger B, Berger U, Telford N, Aruliah S, Yin JA, Vanstraelen D, Barker HF, Taylor PC, O'Driscoll A, Benedetti F, Rudolph C, Kolb HJ, Hochhaus A, Hehlmann R, Chase A and Cross NC. (2005). Cancer Res., 65, 2662-2667.
22. Trempat P, Villalva C, Laurent G, Armstrong F, Delsol G, Dastugue N and Brousset P. (2003). Oncogene, 22, 5702-5706.
23. Valdembri D, Serini G, Vacca A, Ribatti D and Bussolino F. (2002). FASEB J., 16, 225-227.